<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Nowadays, artemisinin and semisynthetic derivatives of similar structure are being developed as a novel class of peroxide-based antimalarial drugs, with activity against multidrug-resistant strains of
 <italic class="italic"> Plasmodium falciparum</italic> and cerebral malaria [
 <xref rid="B7" ref-type="bibr" class="xref">7</xref>, 
 <xref rid="B8" ref-type="bibr" class="xref">8</xref>]. Furthermore, the use of artemisinin-based combination therapy (ACT) is widely recommended by World Health Organization (WHO) in different countries as the most effective one against the drug-resistant parasites. Some data shows that artemisinin becomes cytotoxic in the presence of ferrous iron [
 <xref rid="B9" ref-type="bibr" class="xref">9</xref>].
</p>
